Share Price and Basic Stock Data
Last Updated: December 13, 2025, 9:18 am
| PEG Ratio | 1.83 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vera Synthetic Ltd operates within an undisclosed industry, with its current price standing at ₹69.9 and a market capitalization of ₹34.5 Cr. Over recent years, the company’s revenue trajectory has demonstrated notable fluctuations. For instance, sales recorded an impressive ₹40.71 Cr in Mar 2023, marking a significant increase from ₹34.98 Cr in Mar 2022. However, sales subsequently declined to ₹39.38 Cr in Mar 2024, before showing a rebound to ₹42.03 Cr in Mar 2025. Quarterly sales figures reflect this volatility, with the latest data indicating ₹21.55 Cr for Sep 2023 and projected at ₹21.56 Cr for Mar 2024. This trend suggests that while the company has experienced growth, it also faces challenges in maintaining consistent sales performance. The reported operating profit margin (OPM) for the trailing twelve months is 8.32%, slightly down from previous periods, indicating that operational efficiency is a critical area for improvement.
Profitability and Efficiency Metrics
Vera Synthetic Ltd’s profitability metrics reveal a mixed performance. The company reported a net profit of ₹2.75 Cr in the latest fiscal year, with a return on equity (ROE) of 9.07% and a return on capital employed (ROCE) of 12.3%. These figures indicate a reasonable level of profitability relative to equity and capital employed. However, the company has faced fluctuations in quarterly net profit, including a decline to a loss of ₹0.25 Cr in Sep 2023. The interest coverage ratio (ICR) stands at an impressive 6735.87x, suggesting that the company is exceptionally well-positioned to meet its interest obligations, highlighting a strong financial buffer. Efficiency metrics, such as the cash conversion cycle (CCC) of 96.32 days, indicate that the company takes longer to convert its investments into cash compared to industry norms, which typically range from 30 to 90 days. This extended cycle poses a risk to liquidity and operational efficiency.
Balance Sheet Strength and Financial Ratios
The balance sheet of Vera Synthetic Ltd exhibits a robust structure with minimal debt, as indicated by borrowings of just ₹0.03 Cr. The company’s reserves have grown to ₹20.00 Cr, providing a solid equity base. The debt-to-equity ratio stands at 0.00, reflecting a conservative approach to leverage. The current ratio is reported at 5.44, significantly above the industry average of around 1.5, suggesting excellent short-term liquidity. The price-to-book value (P/BV) ratio is 1.42x, indicating that investors are willing to pay a premium over the book value. The company’s asset turnover ratio of 1.68% reflects efficient use of assets to generate revenue, although it is slightly lower than the sector average. Furthermore, the working capital days have increased to 143.99 days, indicating that the company may face challenges in managing its operational liquidity effectively.
Shareholding Pattern and Investor Confidence
Vera Synthetic Ltd’s shareholding pattern reveals a strong commitment from its promoters, who hold 68.66% of the company. This significant stake indicates a high level of confidence from the founding members in the company’s long-term prospects. The public shareholding stands at 31.34%, showing that external investors have a notable presence, although there are no foreign institutional investors (FIIs) or domestic institutional investors (DIIs) reported. The number of shareholders has fluctuated, currently at 115, suggesting a stable investor base. However, the absence of institutional investors may raise questions about the stock’s liquidity and broader market support. The dividend payout has consistently remained at 0.00%, which may deter income-focused investors but allows the company to reinvest profits back into growth initiatives.
Outlook, Risks, and Final Insight
Looking ahead, Vera Synthetic Ltd faces both opportunities and challenges. The company’s strong balance sheet and low debt levels position it well for growth, particularly if it can enhance its operational efficiency and sales consistency. However, risks include the volatility in profitability, as evidenced by the recent quarterly loss, and the extended cash conversion cycle that could impact liquidity. Additionally, the lack of institutional investor interest may limit market visibility. The company has the potential to leverage its reserves for expansion or innovation, but it must navigate these risks carefully to sustain long-term growth. If the company can improve its operational metrics and attract institutional investment, it could see enhanced market confidence and valuation. Conversely, continued profitability fluctuations and operational inefficiencies may hinder its growth trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 105 Cr. | 27.2 | 796/25.8 | 1.02 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 1,637 Cr. | 162 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 46.0 Cr. | 3.61 | 8.65/3.48 | 4.93 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,557.17 Cr | 221.81 | 405.48 | 219.27 | 0.25% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.01 | 15.56 | 14.70 | 13.43 | 17.40 | 17.58 | 19.61 | 40.71 | 21.55 | 21.56 | 23.28 | 19.11 |
| Expenses | 16.37 | 13.97 | 12.42 | 13.36 | 16.57 | 15.35 | 17.93 | 37.78 | 21.21 | 20.26 | 21.23 | 17.52 |
| Operating Profit | 1.64 | 1.59 | 2.28 | 0.07 | 0.83 | 2.23 | 1.68 | 2.93 | 0.34 | 1.30 | 2.05 | 1.59 |
| OPM % | 9.11% | 10.22% | 15.51% | 0.52% | 4.77% | 12.68% | 8.57% | 7.20% | 1.58% | 6.03% | 8.81% | 8.32% |
| Other Income | 0.00 | 0.00 | 0.00 | 1.03 | 0.31 | -0.05 | 0.05 | 0.17 | 0.01 | 0.00 | 0.11 | 0.00 |
| Interest | 0.10 | 0.09 | 0.07 | 0.09 | 0.07 | 0.09 | 0.07 | 0.16 | 0.05 | 0.05 | 0.00 | 0.00 |
| Depreciation | 0.31 | 0.37 | 0.30 | 0.31 | 0.34 | 0.17 | 0.21 | 0.49 | 0.54 | 0.54 | 0.49 | 0.53 |
| Profit before tax | 1.23 | 1.13 | 1.91 | 0.70 | 0.73 | 1.92 | 1.45 | 2.45 | -0.24 | 0.71 | 1.67 | 1.06 |
| Tax % | 27.64% | 15.93% | 29.84% | 27.14% | 26.03% | 25.52% | 24.14% | 25.71% | 4.17% | 25.35% | 25.15% | 27.36% |
| Net Profit | 0.90 | 0.96 | 1.35 | 0.51 | 0.54 | 1.42 | 1.09 | 1.82 | -0.25 | 0.53 | 1.26 | 0.77 |
| EPS in Rs | 1.82 | 1.95 | 2.74 | 1.03 | 1.09 | 2.88 | 2.21 | 3.69 | -0.51 | 1.07 | 2.55 | 1.56 |
Last Updated: August 20, 2025, 1:30 am
Below is a detailed analysis of the quarterly data for Vera Synthetic Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 19.11 Cr.. The value appears to be declining and may need further review. It has decreased from 23.28 Cr. (Sep 2024) to 19.11 Cr., marking a decrease of 4.17 Cr..
- For Expenses, as of Mar 2025, the value is 17.52 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 21.23 Cr. (Sep 2024) to 17.52 Cr., marking a decrease of 3.71 Cr..
- For Operating Profit, as of Mar 2025, the value is 1.59 Cr.. The value appears to be declining and may need further review. It has decreased from 2.05 Cr. (Sep 2024) to 1.59 Cr., marking a decrease of 0.46 Cr..
- For OPM %, as of Mar 2025, the value is 8.32%. The value appears to be declining and may need further review. It has decreased from 8.81% (Sep 2024) to 8.32%, marking a decrease of 0.49%.
- For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.11 Cr. (Sep 2024) to 0.00 Cr., marking a decrease of 0.11 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.53 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.49 Cr. (Sep 2024) to 0.53 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Mar 2025, the value is 1.06 Cr.. The value appears to be declining and may need further review. It has decreased from 1.67 Cr. (Sep 2024) to 1.06 Cr., marking a decrease of 0.61 Cr..
- For Tax %, as of Mar 2025, the value is 27.36%. The value appears to be increasing, which may not be favorable. It has increased from 25.15% (Sep 2024) to 27.36%, marking an increase of 2.21%.
- For Net Profit, as of Mar 2025, the value is 0.77 Cr.. The value appears to be declining and may need further review. It has decreased from 1.26 Cr. (Sep 2024) to 0.77 Cr., marking a decrease of 0.49 Cr..
- For EPS in Rs, as of Mar 2025, the value is 1.56. The value appears to be declining and may need further review. It has decreased from 2.55 (Sep 2024) to 1.56, marking a decrease of 0.99.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:25 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.58 | 24.32 | 21.89 | 18.13 | 22.15 | 33.73 | 32.29 | 27.76 | 34.98 | 40.70 | 39.38 | 42.03 | 45.19 |
| Expenses | 18.67 | 23.37 | 21.02 | 17.17 | 19.86 | 31.03 | 29.22 | 25.43 | 31.93 | 37.77 | 35.74 | 38.60 | 40.74 |
| Operating Profit | 0.91 | 0.95 | 0.87 | 0.96 | 2.29 | 2.70 | 3.07 | 2.33 | 3.05 | 2.93 | 3.64 | 3.43 | 4.45 |
| OPM % | 4.65% | 3.91% | 3.97% | 5.30% | 10.34% | 8.00% | 9.51% | 8.39% | 8.72% | 7.20% | 9.24% | 8.16% | 9.85% |
| Other Income | 0.18 | 0.18 | 0.06 | 0.02 | 0.10 | 0.17 | 0.17 | 1.05 | 0.26 | 0.17 | 0.07 | 0.33 | 0.00 |
| Interest | 0.33 | 0.35 | 0.13 | 0.10 | 0.37 | 0.25 | 0.19 | 0.16 | 0.16 | 0.16 | 0.08 | 0.00 | 0.00 |
| Depreciation | 0.28 | 0.38 | 0.40 | 0.26 | 0.48 | 0.65 | 0.67 | 0.61 | 0.51 | 0.49 | 1.18 | 1.02 | 0.95 |
| Profit before tax | 0.48 | 0.40 | 0.40 | 0.62 | 1.54 | 1.97 | 2.38 | 2.61 | 2.64 | 2.45 | 2.45 | 2.74 | 3.50 |
| Tax % | 31.25% | 90.00% | 32.50% | 32.26% | 31.17% | 28.93% | 21.85% | 28.74% | 25.76% | 25.71% | 27.35% | 25.91% | |
| Net Profit | 0.33 | 0.05 | 0.27 | 0.43 | 1.06 | 1.40 | 1.85 | 1.86 | 1.97 | 1.82 | 1.80 | 2.03 | 2.75 |
| EPS in Rs | 1.83 | 0.28 | 1.50 | 2.39 | 2.94 | 2.84 | 3.75 | 3.77 | 3.99 | 3.69 | 3.65 | 4.11 | 5.57 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -84.85% | 440.00% | 59.26% | 146.51% | 32.08% | 32.14% | 0.54% | 5.91% | -7.61% | -1.10% | 12.78% |
| Change in YoY Net Profit Growth (%) | 0.00% | 524.85% | -380.74% | 87.25% | -114.44% | 0.07% | -31.60% | 5.37% | -13.53% | 6.52% | 13.88% |
Vera Synthetic Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 6% |
| 3 Years: | 7% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 45% |
| 5 Years: | 2% |
| 3 Years: | 1% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | % |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 1:51 pm
Balance Sheet
Last Updated: December 4, 2025, 2:11 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.80 | 1.80 | 1.80 | 1.80 | 3.60 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 |
| Reserves | 1.61 | 2.40 | 2.67 | 2.33 | 1.58 | 6.70 | 8.55 | 10.41 | 12.38 | 14.20 | 15.99 | 18.02 | 20.00 |
| Borrowings | 3.31 | 1.27 | 0.81 | 0.85 | 5.01 | 1.76 | 1.40 | 1.82 | 1.68 | 1.13 | 0.00 | 0.00 | 0.03 |
| Other Liabilities | 1.79 | 1.59 | 2.04 | 2.89 | 5.12 | 2.29 | 3.37 | 3.44 | 4.52 | 2.92 | 2.52 | 3.78 | 5.65 |
| Total Liabilities | 8.51 | 7.06 | 7.32 | 7.87 | 15.31 | 15.69 | 18.26 | 20.61 | 23.52 | 23.19 | 23.45 | 26.74 | 30.62 |
| Fixed Assets | 2.01 | 2.41 | 2.40 | 1.06 | 3.45 | 3.97 | 4.01 | 4.47 | 3.05 | 6.08 | 6.57 | 5.65 | 5.27 |
| CWIP | 0.37 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 6.13 | 4.28 | 4.92 | 6.81 | 11.86 | 11.72 | 14.25 | 16.14 | 20.47 | 17.11 | 16.88 | 21.09 | 25.35 |
| Total Assets | 8.51 | 7.06 | 7.32 | 7.87 | 15.31 | 15.69 | 18.26 | 20.61 | 23.52 | 23.19 | 23.45 | 26.74 | 30.62 |
Below is a detailed analysis of the balance sheet data for Vera Synthetic Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.94 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.94 Cr..
- For Reserves, as of Sep 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.02 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 1.98 Cr..
- For Borrowings, as of Sep 2025, the value is 0.03 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 0.03 Cr., marking an increase of 0.03 Cr..
- For Other Liabilities, as of Sep 2025, the value is 5.65 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.78 Cr. (Mar 2025) to 5.65 Cr., marking an increase of 1.87 Cr..
- For Total Liabilities, as of Sep 2025, the value is 30.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.74 Cr. (Mar 2025) to 30.62 Cr., marking an increase of 3.88 Cr..
- For Fixed Assets, as of Sep 2025, the value is 5.27 Cr.. The value appears to be declining and may need further review. It has decreased from 5.65 Cr. (Mar 2025) to 5.27 Cr., marking a decrease of 0.38 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 25.35 Cr.. The value appears strong and on an upward trend. It has increased from 21.09 Cr. (Mar 2025) to 25.35 Cr., marking an increase of 4.26 Cr..
- For Total Assets, as of Sep 2025, the value is 30.62 Cr.. The value appears strong and on an upward trend. It has increased from 26.74 Cr. (Mar 2025) to 30.62 Cr., marking an increase of 3.88 Cr..
Notably, the Reserves (20.00 Cr.) exceed the Borrowings (0.03 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -2.40 | -0.32 | 0.06 | 0.11 | -2.72 | 0.94 | 1.67 | 0.51 | 1.37 | 1.80 | 3.64 | 3.43 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54.81 | 46.83 | 45.69 | 36.04 | 136.28 | 82.67 | 92.01 | 83.36 | 89.01 | 82.15 | 27.06 | 37.95 |
| Inventory Days | 50.65 | 13.18 | 21.15 | 31.97 | 38.30 | 5.46 | 28.52 | 51.60 | 30.23 | 38.86 | 68.81 | 84.39 |
| Days Payable | 11.54 | 10.23 | 16.10 | 7.05 | 81.62 | 16.38 | 23.50 | 33.41 | 37.57 | 14.65 | 7.57 | 26.02 |
| Cash Conversion Cycle | 93.91 | 49.77 | 50.74 | 60.97 | 92.96 | 71.76 | 97.02 | 101.55 | 81.67 | 106.36 | 88.30 | 96.32 |
| Working Capital Days | 36.54 | 20.86 | 23.18 | 5.44 | 45.98 | 70.01 | 86.02 | 117.68 | 134.61 | 101.88 | 80.17 | 143.99 |
| ROCE % | 12.31% | 9.86% | 14.04% | 25.18% | 18.82% | 17.96% | 16.47% | 15.48% | 13.29% | 12.28% | 12.26% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| Diluted EPS (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| Cash EPS (Rs.) | 6.18 | 6.02 | 4.67 | 5.01 | 4.99 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 46.51 | 42.41 | 38.77 | 35.08 | 31.09 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 46.51 | 42.41 | 38.77 | 35.08 | 31.09 |
| Revenue From Operations / Share (Rs.) | 85.44 | 79.80 | 82.48 | 70.89 | 56.95 |
| PBDIT / Share (Rs.) | 7.62 | 7.53 | 6.28 | 6.71 | 6.85 |
| PBIT / Share (Rs.) | 5.54 | 5.15 | 5.30 | 5.68 | 5.62 |
| PBT / Share (Rs.) | 5.54 | 4.98 | 4.97 | 5.36 | 5.29 |
| Net Profit / Share (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| PBDIT Margin (%) | 8.91 | 9.43 | 7.61 | 9.46 | 12.03 |
| PBIT Margin (%) | 6.48 | 6.44 | 6.42 | 8.01 | 9.86 |
| PBT Margin (%) | 6.48 | 6.24 | 6.02 | 7.56 | 9.28 |
| Net Profit Margin (%) | 4.80 | 4.56 | 4.46 | 5.62 | 6.60 |
| Return on Networth / Equity (%) | 8.83 | 8.58 | 9.51 | 11.36 | 12.09 |
| Return on Capital Employeed (%) | 11.91 | 12.13 | 13.28 | 15.23 | 16.66 |
| Return On Assets (%) | 7.57 | 7.65 | 7.84 | 8.36 | 9.00 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.02 | 0.06 | 0.08 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.05 | 0.09 | 0.08 |
| Asset Turnover Ratio (%) | 1.68 | 1.69 | 1.74 | 1.59 | 1.45 |
| Current Ratio (X) | 5.44 | 6.58 | 4.80 | 3.95 | 4.00 |
| Quick Ratio (X) | 3.72 | 4.56 | 3.91 | 3.55 | 3.38 |
| Inventory Turnover Ratio (X) | 7.26 | 4.29 | 7.26 | 5.38 | 4.94 |
| Interest Coverage Ratio (X) | 6735.87 | 44.96 | 19.25 | 21.30 | 20.70 |
| Interest Coverage Ratio (Post Tax) (X) | 3633.35 | 22.73 | 12.29 | 13.66 | 12.35 |
| Enterprise Value (Cr.) | 32.30 | 20.24 | 35.29 | 12.33 | 14.28 |
| EV / Net Operating Revenue (X) | 0.76 | 0.51 | 0.86 | 0.35 | 0.50 |
| EV / EBITDA (X) | 8.59 | 5.45 | 11.38 | 3.73 | 4.22 |
| MarketCap / Net Operating Revenue (X) | 0.77 | 0.65 | 0.88 | 0.36 | 0.56 |
| Price / BV (X) | 1.42 | 1.23 | 1.89 | 0.74 | 1.04 |
| Price / Net Operating Revenue (X) | 0.77 | 0.65 | 0.88 | 0.36 | 0.56 |
| EarningsYield | 0.06 | 0.06 | 0.05 | 0.15 | 0.11 |
After reviewing the key financial ratios for Vera Synthetic Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Dec 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Dec 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Dec 24, the value is 4.11. This value is below the healthy minimum of 5. It has increased from 3.64 (Dec 23) to 4.11, marking an increase of 0.47.
- For Diluted EPS (Rs.), as of Dec 24, the value is 4.11. This value is below the healthy minimum of 5. It has increased from 3.64 (Dec 23) to 4.11, marking an increase of 0.47.
- For Cash EPS (Rs.), as of Dec 24, the value is 6.18. This value is within the healthy range. It has increased from 6.02 (Dec 23) to 6.18, marking an increase of 0.16.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Dec 24, the value is 46.51. It has increased from 42.41 (Dec 23) to 46.51, marking an increase of 4.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Dec 24, the value is 46.51. It has increased from 42.41 (Dec 23) to 46.51, marking an increase of 4.10.
- For Revenue From Operations / Share (Rs.), as of Dec 24, the value is 85.44. It has increased from 79.80 (Dec 23) to 85.44, marking an increase of 5.64.
- For PBDIT / Share (Rs.), as of Dec 24, the value is 7.62. This value is within the healthy range. It has increased from 7.53 (Dec 23) to 7.62, marking an increase of 0.09.
- For PBIT / Share (Rs.), as of Dec 24, the value is 5.54. This value is within the healthy range. It has increased from 5.15 (Dec 23) to 5.54, marking an increase of 0.39.
- For PBT / Share (Rs.), as of Dec 24, the value is 5.54. This value is within the healthy range. It has increased from 4.98 (Dec 23) to 5.54, marking an increase of 0.56.
- For Net Profit / Share (Rs.), as of Dec 24, the value is 4.11. This value is within the healthy range. It has increased from 3.64 (Dec 23) to 4.11, marking an increase of 0.47.
- For PBDIT Margin (%), as of Dec 24, the value is 8.91. This value is below the healthy minimum of 10. It has decreased from 9.43 (Dec 23) to 8.91, marking a decrease of 0.52.
- For PBIT Margin (%), as of Dec 24, the value is 6.48. This value is below the healthy minimum of 10. It has increased from 6.44 (Dec 23) to 6.48, marking an increase of 0.04.
- For PBT Margin (%), as of Dec 24, the value is 6.48. This value is below the healthy minimum of 10. It has increased from 6.24 (Dec 23) to 6.48, marking an increase of 0.24.
- For Net Profit Margin (%), as of Dec 24, the value is 4.80. This value is below the healthy minimum of 5. It has increased from 4.56 (Dec 23) to 4.80, marking an increase of 0.24.
- For Return on Networth / Equity (%), as of Dec 24, the value is 8.83. This value is below the healthy minimum of 15. It has increased from 8.58 (Dec 23) to 8.83, marking an increase of 0.25.
- For Return on Capital Employeed (%), as of Dec 24, the value is 11.91. This value is within the healthy range. It has decreased from 12.13 (Dec 23) to 11.91, marking a decrease of 0.22.
- For Return On Assets (%), as of Dec 24, the value is 7.57. This value is within the healthy range. It has decreased from 7.65 (Dec 23) to 7.57, marking a decrease of 0.08.
- For Long Term Debt / Equity (X), as of Dec 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Dec 23) which recorded 0.00.
- For Total Debt / Equity (X), as of Dec 24, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Dec 23) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Dec 24, the value is 1.68. It has decreased from 1.69 (Dec 23) to 1.68, marking a decrease of 0.01.
- For Current Ratio (X), as of Dec 24, the value is 5.44. This value exceeds the healthy maximum of 3. It has decreased from 6.58 (Dec 23) to 5.44, marking a decrease of 1.14.
- For Quick Ratio (X), as of Dec 24, the value is 3.72. This value exceeds the healthy maximum of 2. It has decreased from 4.56 (Dec 23) to 3.72, marking a decrease of 0.84.
- For Inventory Turnover Ratio (X), as of Dec 24, the value is 7.26. This value is within the healthy range. It has increased from 4.29 (Dec 23) to 7.26, marking an increase of 2.97.
- For Interest Coverage Ratio (X), as of Dec 24, the value is 6,735.87. This value is within the healthy range. It has increased from 44.96 (Dec 23) to 6,735.87, marking an increase of 6,690.91.
- For Interest Coverage Ratio (Post Tax) (X), as of Dec 24, the value is 3,633.35. This value is within the healthy range. It has increased from 22.73 (Dec 23) to 3,633.35, marking an increase of 3,610.62.
- For Enterprise Value (Cr.), as of Dec 24, the value is 32.30. It has increased from 20.24 (Dec 23) to 32.30, marking an increase of 12.06.
- For EV / Net Operating Revenue (X), as of Dec 24, the value is 0.76. This value is below the healthy minimum of 1. It has increased from 0.51 (Dec 23) to 0.76, marking an increase of 0.25.
- For EV / EBITDA (X), as of Dec 24, the value is 8.59. This value is within the healthy range. It has increased from 5.45 (Dec 23) to 8.59, marking an increase of 3.14.
- For MarketCap / Net Operating Revenue (X), as of Dec 24, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.65 (Dec 23) to 0.77, marking an increase of 0.12.
- For Price / BV (X), as of Dec 24, the value is 1.42. This value is within the healthy range. It has increased from 1.23 (Dec 23) to 1.42, marking an increase of 0.19.
- For Price / Net Operating Revenue (X), as of Dec 24, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.65 (Dec 23) to 0.77, marking an increase of 0.12.
- For EarningsYield, as of Dec 24, the value is 0.06. This value is below the healthy minimum of 5. There is no change compared to the previous period (Dec 23) which recorded 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vera Synthetic Ltd:
- Net Profit Margin: 4.8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.91% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.83% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3633.35
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 12.6 (Industry average Stock P/E: 405.48)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.8%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Textiles - Synthetic/Silk | Office No.UL-27, Pattani Plaza, Bhavnagar Gujarat 364002 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sunil D Makwana | Chairman & Managing Director |
| Mrs. Meera S Makwana | Whole Time Director |
| Mr. Devjibhai P Makwana | Executive Director |
| Mr. Dineshbhai M Patel | Independent Director |
| Mrs. Bansari Parin Shah | Independent Director |
| Mr. Ravikumar B Adhiya | Independent Director |
FAQ
What is the intrinsic value of Vera Synthetic Ltd?
Vera Synthetic Ltd's intrinsic value (as of 25 December 2025) is 47.09 which is 32.63% lower the current market price of 69.90, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 34.5 Cr. market cap, FY2025-2026 high/low of 100/66.0, reserves of ₹20.00 Cr, and liabilities of 30.62 Cr.
What is the Market Cap of Vera Synthetic Ltd?
The Market Cap of Vera Synthetic Ltd is 34.5 Cr..
What is the current Stock Price of Vera Synthetic Ltd as on 25 December 2025?
The current stock price of Vera Synthetic Ltd as on 25 December 2025 is 69.9.
What is the High / Low of Vera Synthetic Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vera Synthetic Ltd stocks is 100/66.0.
What is the Stock P/E of Vera Synthetic Ltd?
The Stock P/E of Vera Synthetic Ltd is 12.6.
What is the Book Value of Vera Synthetic Ltd?
The Book Value of Vera Synthetic Ltd is 50.5.
What is the Dividend Yield of Vera Synthetic Ltd?
The Dividend Yield of Vera Synthetic Ltd is 0.00 %.
What is the ROCE of Vera Synthetic Ltd?
The ROCE of Vera Synthetic Ltd is 12.3 %.
What is the ROE of Vera Synthetic Ltd?
The ROE of Vera Synthetic Ltd is 9.07 %.
What is the Face Value of Vera Synthetic Ltd?
The Face Value of Vera Synthetic Ltd is 10.0.